Publication Name	World Journal of Clinical Oncology
Manuscript ID	47010
Country	Japan

Received	2019-03-02 06:56
Peer-Review Started	2019-03-04 10:43
To Make the First Decision	2019-08-06 06:36
Return for Revision	2019-08-08 08:07
Revised	2019-08-17 08:40
Second Decision	2019-08-21 08:50
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2019-08-21 23:37
Articles in Press	2019-08-21 23:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-09-04 01:20
Publish the Manuscript Online	2019-09-30 02:18

ISSN	2218-4333 (online)
Open Access	This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Gangliocytic paraganglioma: An overview and future perspective
Manuscript Source	Invited Manuscript
All Author List	Yoichiro Okubo
ORCID	Author(s) ORCID Number Yoichiro Okubo http://orcid.org/0000-0002-7079-4454
Funding Agency and Grant Number	Funding Agency Grant Number Ministry of Education, Culture, Sports, Science, and Technology of Japan JP17K08713 Kanagawa Prefectural Hospitals Cancer Fund 20182019-Nenndo
Corresponding Author	Yoichiro Okubo, MD, PhD, Assistant Professor, Doctor, Doctor, Department of Pathology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ku, Yokohama 241-8515, Kanagawa, Japan. yoichiro0207@hotmail.com
Key Words	Neuroendocrine tumor; Gangliocytic paraganglioma; Progesterone receptor; Pancreatic polypeptide; Literature survey;
Core Tip	Although gangliocytic paraganglioma (GP) has been regarded as a rare neuroendocrine tumor (NET), GP accounts for a significant number of duodenal NETs. Morphological and immunohistochemical similarities between GP and NET G1 often lead to misdiagnoses of both. However, the prognosis is often better for patients with GP than for those with NET G1. Therefore, it is important to differentiate GP from NET G1. This editorial provides up-to-date data on the clinicopathological characteristics of GP and emphasizes the importance of confirming progesterone receptor and pancreatic polypeptide immunoreactivity for differentiating GP from NET G1.
Publish Date	2019-09-30 02:18
Citation	Okubo Y. Gangliocytic paraganglioma: An overview and future perspective. World J Clin Oncol 2019; 10(9): 300-302
URL	https://www.wjgnet.com/2218-4333/full/v10/i9/300.htm
DOI	https://dx.doi.org/10.5306/wjco.v10.i9.300

Full Article (PDF)	WJCO-10-300.pdf
Full Article (Word)	WJCO-10-300.docx
Manuscript File	47010-Review.docx
Answering Reviewers	47010-Answering reviewers.pdf
Audio Core Tip	47010-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	47010-Conflict-of-interest statement.pdf
Copyright License Agreement	47010-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	47010-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	47010-Language certificate.pdf
Peer-review Report	47010-Peer-review(s).pdf
Scientific Misconduct Check	47010-Scientific misconduct check.pdf
Scientific Editor Work List	47010-Scientific editor work list.pdf
CrossCheck Report	47010-CrossCheck report.pdf